Skip to main content

Day: January 4, 2022

First Wave BioPharma to Participate in Two Investor Conferences in January 2022

CEO James Sapirstein to Moderate Panel Discussion during Longwood Healthcare Leaders Conference and Host Virtual Presentation at H.C. Wainwright BioConnect 2022 BOCA RATON, Fla., Jan. 04, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that President and Chief Executive Officer James Sapirstein will participate in the Longwood Healthcare Leaders Conference and H.C. Wainwright BioConnect 2022. Both events will be held virtually. At the Longwood Healthcare Leaders Conference taking place January 6-7, 2022, Mr. Sapirstein will moderate a panel discussion focused on novel therapeutic modalities. Joining Mr. Sapirstein...

Continue reading

Baudax Bio to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

MALVERN, Pa., Jan. 04, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced that Gerri Henwood, the Company’s President and Chief Executive Officer, will present at the H.C. Wainwright BIOCONNECT Virtual Conference being held January 10 – 13, 2022. The presentation will be made available for on-demand listening beginning Monday, January 10, 2022 at 7:00 a.m. Eastern Time and may be accessed on the “Events” page within the investors section of the Baudax Bio website at https://www.baudaxbio.com/news-and-investors. A replay will be available on the Baudax Bio website for a period of 30 days following the event. About Baudax Bio Baudax Bio is a pharmaceutical company focused on commercializing and...

Continue reading

PROCEPT BioRobotics Appoints Mary Garrett to Board of Directors

REDWOOD CITY, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) — PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced the appointment of Mary Garrett to its Board of Directors. Ms. Garrett most recently served on the board of Hillrom Corporation which was acquired by Baxter International Inc. in December 2021. Ms. Garrett was the governance committee chair and served on the audit committee of Hill-Rom. She also previously served as a board member and was on the audit committee of Ethan Allen Interiors, Inc. Prior to these roles and her retirement in 2015, Ms. Garrett was the Chief Marketing Officer, Global Markets for IBM Corporation. “Ms. Garrett’s impressive understanding of the technology industry and expertise...

Continue reading

Mirasol Resources Promotes Carmen Cazares to CFO

VANCOUVER, British Columbia, Jan. 04, 2022 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V: MRZ) (OTCPK: MRZLF) (the “Company” or “Mirasol”) is pleased to announce the promotion of Carmen Cazares to Chief Financial Officer (“CFO”). Ms. Cazares joined Mirasol in 2019 and previously served as the Company’s Corporate Controller. Ms. Cazares, CPA, CGA, is a member of the Chartered Professional Accountants of British Columbia and has a broad operational and accounting background with more than 30 years of experience. Prior to joining Mirasol, she served as Corporate Controller at Coro Mining Corp. in Vancouver and at Endeavour Silver Corp. in Mexico. Ms. Cazares earned a Bachelor of Commerce Degree from the University of Chihuahua, Mexico. Patrick Evans, Mirasol’s Executive Chair commented: “Carmen has performed exceptionally well...

Continue reading

Bitfarms to Present at the 24th Annual Needham Growth Conference on January 14th

Presentation on Friday, January 14, 2022 at 10:45 AM ET TORONTO, Ontario and BROSSARD, Québec, Jan. 04, 2022 (GLOBE NEWSWIRE) — Bitfarms Ltd. (NASDAQ: BITF // TSXV: BITF), a global Bitcoin self-mining company, will be presenting at the upcoming virtual 24th Annual Needham Growth Conference on Friday, January 14th, at 10:45 AM ET. President and Chief Operating Officer, Geoffrey Morphy, and Chief Financial Officer, Jeff Lucas, will be giving the presentation.Event: Bitfarms Virtual Presentation at the 24th Annual Needham Growth ConferenceDate: Friday, January 14th, 2022Time: 7:45 AM PT/ 10:45 AM ETThe Company’s presentation will be webcast live and available for replay here. For additional information or to schedule a virtual one-on-one meeting with Bitfarms’ management, please contact your Needham representative or Bitfarms’...

Continue reading

BioXcel Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

NEW HAVEN, Conn., Jan. 04, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that Vimal Mehta, Ph.D., CEO of BioXcel Therapeutics, will present corporate updates and plans for 2022 at the 40th Annual J.P. Morgan Healthcare Conference, being held virtually, on Thursday, January 13, 2022 at 9:45 a.m. ET. To access the live webcast of the presentation and the Company’s accompanying presentation materials, please visit “News/Events” within the Investors & Media section of the Company’s website at www.bioxceltherapeutics.com beginning 15 minutes prior to the start time of the presentation. A replay of the webcast will be available...

Continue reading

Orchard Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

BOSTON and LONDON, Jan. 04, 2022 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the company is scheduled to present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Thursday January 13, 2022, at 9:00 a.m. ET. A live webcast of the presentation and breakout session will be available under “News & Events” in the Investors & Media section of the company’s website at www.orchard-tx.com. Webcast replays will be archived on the Orchard website following the presentation. About Orchard TherapeuticsAt Orchard Therapeutics, our vision is to end the devastation caused by genetic and other severe diseases. We aim to do this by discovering, developing and commercializing new treatments that tap into the curative potential of hematopoietic...

Continue reading

OTC Markets Group Welcomes OM Holdings International, Inc. to OTCQX

NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced OM Holdings International, Inc. (OTCQX: OMHI), a provider of a multi-tenant on-demand technology platform for the delivery of goods and services throughout the Caribbean, has qualified to trade on the OTCQX® Best Market. OM Holdings International, Inc. upgraded to OTCQX from the Pink® market. OM Holdings International, Inc. begins trading today on OTCQX under the symbol “OMHI.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market provides investors with a premium U.S. public market to research and trade the shares of investor-focused companies. Graduating to the OTCQX Market marks...

Continue reading

Cellebrite Supports The Exodus Road’s Efforts to Stop Human Trafficking in Brazil

The collaboration will focus on delivering counter-trafficking training for an estimated 20,000 Brazilian police officers TYSONS CORNER, Va., Jan. 04, 2022 (GLOBE NEWSWIRE) — Cellebrite (Nasdaq: CLBT), a global leader in Digital Intelligence (DI) solutions for the public and private sectors, and The Exodus Road, a Colorado-based nonprofit organization specializing in disrupting human trafficking, announced today a collaboration focused on training police and government officials in Brazil to combat human trafficking more effectively. The collaboration has delivered the launch of The Exodus Road’s training platform, TraffickWatch Academy: Brazil, featuring Brazilian and U.S. experts on human-trafficking crime. Cellebrite has committed to provide The Exodus Road funding and in-kind solutions and services over the next three years...

Continue reading

Global Tech Brand Powerhouse Future Reveals Most Influential Tech Leaders & Products

Future Tech Awards Recognize World’s Biggest Tech Influencers and Product Innovations NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) — Number one destination for tech content Future plc has unveiled the winners of its prestigious Future Tech Awards, which recognize 50 of the most influential leaders in tech alongside the leading technology product innovations and challenger technology brands. The awards celebrate the individuals and products driving innovation in consumer technology, and share valuable insight with Future’s global audience of over 300 million on who is effecting change and striving for excellence in the tech industry. The Future 50 included familiar luminaries like Tesla CEO Elon Musk and Microsoft CEO Satya Nadella, along with outstanding upstarts like teen scientist Neha Shukla, who created a life-saving wearable...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.